Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders.
Genetically engineered mice were originally generated to delineate the role of a specific gene product in behavioral or neuroendocrine phenotypes, rather than to produce classic animal models of depression. To learn more about the neurobiological mechanisms underlying a clinical condition such as depression, it has proven worthwhile to investigate changes in behaviors characteristic of depressed humans, such as anxiety, regardless of whether or not these alterations may also occur in other disorders besides depression. The majority of patients with mood and anxiety disorders have measurable shifts in their stress hormone regulation as reflected by elevated secretion of central and peripheral stress hormones or by altered hormonal responses to neuroendocrine challenge tests. In recent years, these alterations have been increasingly translated into testable hypotheses addressing the pathogenesis of illness. Refined molecular technologies and the creation of genetically engineered mice have allowed to specifically target individual genes involved in regulation of corticotropin releasing factor (CRF) system elements (e.g. CRF and CRF-related peptides, their receptors, binding protein). Studies performed in such mice have complemented and extended our knowledge. The cumulative evidence makes a strong case implicating dysfunction of these systems in the pathogenesis of depression and leads us beyond the monoaminergic synapse in search of eagerly anticipated strategies to discover and develop better therapies for depression.
Keck
Martin E
ME
Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany. keck@mpipsykl.mpg.de
Ohl
Frauke
F
Holsboer
Florian
F
Müller
Marianne B
MB
D000818:Animals; D001007:Anxiety / Q000378:metabolism; D001522:Behavior, Animal / Q000502:physiology; D003346:Corticotropin-Releasing Hormone / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D008032:Limbic System / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D008817:Mice, Mutant Strains / Q000502:physiology; D008822:Mice, Transgenic / Q000502:physiology*; D019964:Mood Disorders / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D010913:Pituitary-Adrenal System / Q000502:physiology; D011485:Protein Binding / Q000502:physiology; D018019:Receptors, Corticotropin-Releasing Hormone / Q000145:classification / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
D018019:Receptors, Corticotropin-Releasing Hormone; D003346:Corticotropin-Releasing Hormone